- Home
- ARWR vs BCRX Comparison
ARWR vs BCRX Comparison
Compare ARWR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- BCRX
- Stock Information
- Founded
- ARWR 2003
- BCRX 1986
- Country
- ARWR United States
- BCRX United States
- Employees
- ARWR N/A
- BCRX N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARWR Health Care
- BCRX Health Care
- Exchange
- ARWR Nasdaq
- BCRX Nasdaq
- Market Cap
- ARWR 1.7B
- BCRX 1.7B
- IPO Year
- ARWR 1993
- BCRX 1994
- Fundamental
- Price
- ARWR $11.24
- BCRX $7.40
- Analyst Decision
- ARWR Buy
- BCRX Buy
- Analyst Count
- ARWR 11
- BCRX 6
- Target Price
- ARWR $41.44
- BCRX $15.67
- AVG Volume (30 Days)
- ARWR 2.3M
- BCRX 3.2M
- Earning Date
- ARWR 05-08-2025
- BCRX 05-05-2025
- Dividend Yield
- ARWR N/A
- BCRX N/A
- EPS Growth
- ARWR N/A
- BCRX N/A
- EPS
- ARWR N/A
- BCRX N/A
- Revenue
- ARWR $2,500,000.00
- BCRX $450,712,000.00
- Revenue This Year
- ARWR $4,380.43
- BCRX $27.64
- Revenue Next Year
- ARWR $64.24
- BCRX $13.42
- P/E Ratio
- ARWR N/A
- BCRX N/A
- Revenue Growth
- ARWR N/A
- BCRX 36.00
- 52 Week Low
- ARWR $9.57
- BCRX $4.03
- 52 Week High
- ARWR $30.41
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- ARWR 38.40
- BCRX 50.46
- Support Level
- ARWR $9.64
- BCRX $6.02
- Resistance Level
- ARWR $12.93
- BCRX $7.41
- Average True Range (ATR)
- ARWR 1.18
- BCRX 0.44
- MACD
- ARWR 0.18
- BCRX 0.06
- Stochastic Oscillator
- ARWR 43.21
- BCRX 81.66
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.